RNA Splicing: Basic Aspects Underlie Antitumor Targeting

Alzahraa A M Fergany1, Victor V Tatarskiy2

  • 1Department of Occupational and Environmental Health, Graduate School of Pharmaceutical Science, Tokyo University of Science, Chiba, Japan.

Abstract

Insights

RNA splicing, a key gene expression process, is crucial in cancer. Aberrant splicing drives tumor progression and affects drug response, offering new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • RNA splicing is essential for gene expression, involving intron removal and exon arrangement to create functional proteins.
  • Aberrant RNA splicing is increasingly recognized as a significant factor in cancer development and progression.

Purpose of the Study:

  • To review the critical role of RNA splicing in cancer biology.
  • To highlight splicing abnormalities as potential therapeutic targets for cancer treatment.

Main Methods:

  • Discussion of the literature on mRNA splicing in carcinogenesis.
  • Analysis of the impact of aberrant splicing on patient response to cancer therapies.

Main Results:

  • Aberrant mRNA splicing contributes to the initiation and advancement of various cancers.
  • Splicing alterations can influence the efficacy of chemotherapy and targeted drug treatments.

Conclusions:

  • Dysregulated RNA splicing is a clinically relevant mechanism in cancer.
  • Targeting RNA splicing pharmacologically presents a promising avenue for novel cancer therapies.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
59.8K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.6K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.3K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.9K